Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine samples of pregnant women presenting with urinary tract infections with asymptomatic bacteriuria in different hospitals in Abakaliki, Ebonyi State
DOI:
https://doi.org/10.51412/psnnjp.2025.28Abstract
Background: Pseudomonas aeruginosa organisms are notorious for their intrinsic resistance to multiple antibiotics and have been seriously implicated in urinary tract infections (UTIs). In this study, the prevalence and antibiogram of Pseudomonas aeruginosa isolated from the urine samples of pregnant women hospitalized at different clinics was investigated.
Methods: A total of fifty (50) urine samples obtained by informed consent from pregnant women were cultured on Centrimide agar for the isolation of P. aeruginosa. Significant growth was sub-cultured on Centrimide agar for microbiological analysis. Various physical and biochemical tests as well as antimicrobial susceptibility test were carried out on the isolates.
Results: A prevalence rate of 45% observed for P. aeruginosa was considered high (n=22). The prevalence of P. aeruginosa among pregnant women in relation to age and educational status revealed that the observed changes are likely to have occurred by chance at α = 0.05. The antimicrobial susceptibility test revealed that drugs found most effective against P. aeruginosa were Gentamicin, Imipenem and Ciprofloxacin, while the other antibiotics used showed little or no effect.
Conclusion: Routine check of UTIs due to Pseudomonas aeruginosa is advocated in pregnant women especially in hospitalized cases.
References
Djordjevic Z, Folic MM, Zivic Z and Jankovic SM (2013) Nosocomial urinary tract infections caused by sensitivity to antibiotics and Acinetobacter species: sensitivity to antibiotics and risk factors. American Journal of Infection Control, 41: 1182-1187.
Horcajada JP, Show E, Padilla B and Pintado V (2013) Healthcare- associated, community acquired and Hospital-acquired bacteraemic
urinary tract infections in hospitalized patients. Clinical Microbiology and Infection, 9: 962-968.
Hirino T, Chiba A, Kawano S and Kato T (2012) Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa. Internal Medicine Journal, 51: 59-64.
Jarvis WR (1992) Predominant pathogens in hospital infections. Journal of Antimicrobial Chemotherapy, 29: 19-20.
Williams DH, Schaeffer AJ (2004) Current concept in urinary tract infections. Minerva Urology and Nephrology, 56: 15-31
Kerr FG, Snelling AM (2009) Pseudomonas aeruginosa a formidable and ever-present adversary. Journal of Hospital Infection, 73(4): 3338-44
Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: aSystematic review of the literature. Journal of Hospital Infection, 64: 37-25.
Penaranda, C., Chumbler, N. M., Hung, D. T. and Guillard, T. (2021). Dual transcriptional analysis reveals adaptation of hosts and pathogen to
intercellular survival of Pseudomonas aeruginosa associated with urinary tract infection. PLOS Pathogens, 17: e1009534
Ortona L, Federico G, Fanton M, Ardito F, Branca G (2015) A study on the incidence of nosocomial infections in a large university hospital. European Journal of Epidemiology, 1:4-9.
Tuon FF, Dantas LR, Suss PH, Ribeiro VST (2022) Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review Pathogens, 11(3):300. doi: 10.3390/pathogens11030300
Boles BR, Thoendel M, Singh PK (2004) Self-generated diversity procedure “insurance effect” biofilm communities. Proceedings of the National Academy of Sciences of the United States of America, 101: 16630-16635.
Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative
therapeutic strategies. Biotechnology Advances, 37(1): 177-192.
Ammerlaan HS, Harbarth S, Buiting AG (2013) Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase
the total burden of infection. Clinical Infectious Diseases, 56(6): 798-805.
Cuttaneo C, Antoniazzi F, Casari S (2012) P. aeruginosa bloodstream infections among hematological patients: and old news question?
Annals of Hematology Journal, 91(8): 1299-1304.
Ironmonger D, Edeghere O, Bains A, Log R, Woodford N (2015) Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infection and Immunity Journal, 69: 4572-4579.
Cottalorda A, Leoz M, Dahyot S, Gravey F, Grand M (2021) Within-host microevolution of Pseudomonas aeruginosa urinary isolates seven- patient Longitudinal Genomic and Phenotypic study. Frontiers in Microbiology, 11: 611246.
Paul M, Leibovaci L (2013) Editorial commenting: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand? Clinical Infectious Diseases, 57(2): 217-220.
Narten M, Rosin N, Schobert M, Tielen P (2012) Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Current Microbiology, 64(1):7-16. doi: 10.1007/s00284-011-0026-y.
Cheesbrough M (2006) District Laboratory Practice in Tropical Countries. Part 2, 2nd Edition, Cambridge University Press Publication, South Africa, 1-434.
CLSI—Clinical and Laboratory Standards Institute (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of
Filamentous Fungi. Approved Standard M38-A2, 2nd Edition, Wayne, 37 p.
Jones RN, Stilwell MG, Hogan PA, Rennie RP (2014) Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United State. Clinical Therapeutic, 38(7): 1614-1625.
Chang SL, Shortliffe LD (2006) Pediatric urinary tract infections. Pediatric Clinics of North America, 53: 379-4000.
Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-month, 49: 53-70.
Nawaz U, Siddesh B (2012) Prevalence of urinary tract infection in pregnant women. Sirwar Journal of Evolution of Medical and Dental Sciences, 4(1): 315-317.
Smaill F (2007). Assymtomatic bacteruria in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 21(3): 439-450.
Lawani EU, Alade T, Oyelarah D (2015) Urinary tract infection amongst pregnant women in Amassoma, Southern Nigeria. African Journal of
Microbiology Research, 9(6): 355-359.
Ahmed SM, Avasara AK (2008) Urinary tract infections among adolescent girls in rural Karimmaga District. Indian Journal of Preventive & Social Medicine, 39: 1-2.
Omoregie R, Erebor JO, Ahonkhani I, Iobor JO (2008) Observed changes in the prevalence of uropathogens in Benin-city, Nigeria. New Zealand Journal of Medical Laboratory Science, 62:29-31.
Gajdacs, M., Burian, K. and Terhes, G. (2019). Resistance levels and epidemiology of non-fermenting Gram-negative bacteria in urinary
tract infections of inpatients and outpatients: a 10-year epidemiological snapshot. Antibiotics. 9; 8(3): 143. doi: 10.3390/antibiotics8030143
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Nigerian Journal of Pharmacy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
